MedPath

To study the effect of Panchakarma Essential in reducing symptoms with cardiopulmonarydisorders

Not Applicable
Conditions
Health Condition 1: I249- Acute ischemic heart disease, unspecified
Registration Number
CTRI/2023/11/060197
Lead Sponsor
Mprex Healthcare Pvt.Ltd. Wakad, pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Male and female subjects 30-60 years of age (both inclusive).2.Subjects diagnosed with Ischemic Heart Disease, Post Myocardial infarction, and Insomnia will be included.3.Subjects with pulse rate more than 90 per minute.4.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.

Exclusion Criteria

1.Female subjects, who are pregnant, breastfeeding, or planning to

become pregnant.

2.History of major surgical intervention will be excluded.

3.History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the efficacy of Panchakarma Essential in reducing cardiopulmonary disorders. <br/ ><br>2. To assess the improvement in circulation of blood in the body & cardio-respiratory functions.Timepoint: Seven Sessions in two week period
Secondary Outcome Measures
NameTimeMethod
1.To assess the improvement in insomnia. <br/ ><br>2.To assess the improvement in the Quality of life of a patient.Timepoint: Seven Sessions in two week period
© Copyright 2025. All Rights Reserved by MedPath